author-photo

Kambiz Mansouri

16

Papers

563

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy (NACT) for early breast cancer: Three-year follow-up data.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A randomized, controlled, open label phase II study of erlotinib (E) with or without the MET antibody emibetuzumab (Emi) as first-line treatment for EGFRmt non-small cell lung cancer (NSCLC) patients who have disease control after an 8-week lead-in treatment with erlotinib.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
FULVESTRANT (FUL) PLUS ENZASTAURIN (ENZA) VS FUL PLUS PLACEBO (PBO) IN AROMATASE INHIBITOR (AI)-RESISTANT METASTATIC BREAST CANCER (MBC): A RANDOMIZED, DOUBLE-BLIND, PHASE 2 TRIAL

2012 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
A comparative randomized, placebo-controlled, double-blind phase II study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment for advanced ovarian cancer.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer

2011 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (15)
0178 Results of clinical endpoints of a randomized phase II trial with doxorubicin + pemetrexed followed by docetaxel versus doxorubicin + cyclophosphamide followed by docetaxel as primary systemic therapy for early breast cancer

2009 The Breast
Show All
- Source
- Cite
- Save
Citations (1)
Doxorubicin/Pemetrexed Followed by Docetaxel Versus Doxorubicin/Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment for Early-Stage Breast Cancer: A Randomized Phase II Trial

2007 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Gemcitabine and interferon-alpha 2b in solid tumors: a phase I study in patients with advanced or metastatic non-small cell lung, ovarian, pancreatic or renal cancer.

2002 Anti-Cancer Drugs
Show All
- Source
- Cite
- Save
Citations (6)
Identification of stsC, the gene encoding the L-glutamine:scyllo-inosose aminotransferase from streptomycin-producing Streptomycetes.

1997 Archives of Microbiology
Show All
- Source
- Cite
- Save
Citations (55)
Streptomycin biosynthesis and its regulation in Streptomycetes

1992 Gene
Show All
- Source
- Cite
- Save
Citations (89)